| This article has been cited by |
| 1 | Frequency and causes of prevalence of p.Arg894* mutation in CLCN1 gene responsible for development of thomsen’s and becker’s myotonias in russian population | |
| E. A. Ivanova,A. V. Polyakov |
| Russian Journal of Genetics.2013;49(12)1227 |
| [DOI] |
|
| 2 | Frequency and causes of prevalence of p.Arg894* mutation in CLCN1 gene responsible for development of thomsen’s and becker’s myotonias in russian population | |
| Elka Miller,Nagwa Wilson |
| Russian Journal of Genetics.2015;49(12)827 |
| [DOI] |
|
| 3 | Phenotypic Variability in Childhood of Skeletal Muscle Sodium Channelopathies | |
| Harumi Yoshinaga,Shunichi Sakoda,Takashi Shibata,Tomoyuki Akiyama,Makio Oka,Jun-Hui Yuan,Hiroshi Takashima,Masanori P. Takahashi,Tetsuro Kitamura,Nagako Murakami,Katsuhiro Kobayashi |
| Pediatric Neurology.2015;52(5)504 |
| [DOI] |
|
| 4 | Assessment of Premutation in Myotonic Dystrophy Type 1 Affected Family Members by TP-PCR and Genetic Counseling | |
| Ashok Kumar,Sarita Agarwal,Sunil Pradhan |
| Case Reports in Medicine.2014;2014(5)1 |
| [DOI] |
|
| 5 | Positive muscle phenomena—diagnosis, pathogenesis and associated disorders | |
| Hans G. Kortman,Jan H. Veldink,Gea Drost |
| Nature Reviews Neurology.2012;8(2)97 |
| [DOI] |
|
| 6 | Clinical implication of maximal voluntary ventilation in myotonic muscular dystrophy | |
| Mi Ri Suh,Dong Hyun Kim,Jiho Jung,Bitnarae Kim,Jang Woo Lee,Won Ah Choi,Seong-Woong Kang |
| Medicine.2019;98(18)e15321 |
| [DOI] |
|
| 7 | Understanding the Experience of Myotonic Dystrophy. Mixed Method Study | |
| Amy Østertun Geirdal,Inger Lund-Petersen,Arvid Heiberg |
| Journal of Genetic Counseling.2015;24(1)169 |
| [DOI] |
|
| 8 | Perspectives on gene therapy in myotonic dystrophy type 1 | |
| Jonathan J. Magaña,Bulmaro Cisneros |
| Journal of Neuroscience Research.2011;89(3)275 |
| [DOI] |
|
| 9 | Perspectives on gene therapy in myotonic dystrophy type 1 | |
| Satish V. Khadilkar,Rakhil S. Yadav,Bhagyadhan A. Patel |
| Journal of Neuroscience Research.2018;89(3)197 |
| [DOI] |
|
| 10 | Perspectives on gene therapy in myotonic dystrophy type 1 | |
| Satish V. Khadilkar,Rakhil S. Yadav,Bhagyadhan A. Patel |
| Journal of Neuroscience Research.2018;89(3)311 |
| [DOI] |
|
| 11 | Hashimoto Thyroiditis Presenting with a Transient Myotonia | |
| Sang-Soo Lee,Minju Cha,Minju Yeo |
| Journal of the Korean Neurological Association.2018;36(1)49 |
| [DOI] |
|
| 12 | An Up-to-Date Overview of the Complexity of Genotype-Phenotype Relationships in Myotonic Channelopathies | |
| Fernando Morales,Michael Pusch |
| Frontiers in Neurology.2020;10(1)49 |
| [DOI] |
|
| 13 | Association between basal, squamous cell carcinomas, dysplastic nevi and myotonic muscular dystrophy indicates an important role of RNA-binding proteins in development of human skin cancer | |
| Alexander Zemtsov |
| Archives of Dermatological Research.2010;302(3)169 |
| [DOI] |
|
| 14 | Association between basal, squamous cell carcinomas, dysplastic nevi and myotonic muscular dystrophy indicates an important role of RNA-binding proteins in development of human skin cancer | |
| Arthur J. L. Cooper,John P. Blass |
| Archives of Dermatological Research.2011;1(3)319 |
| [DOI] |
|
| 15 | An unusual case with myotonia | |
| Yu-Wei Da,Min Wang,Yun Li,Yan Lu,Jian-Ping Jia |
| The Kaohsiung Journal of Medical Sciences.2013;29(3)172 |
| [DOI] |
|
| 16 | Therapeutics development in myotonic dystrophy type 1 | |
| Erin Pennock Foff,Mani S. Mahadevan |
| Muscle & Nerve.2011;44(2)160 |
| [DOI] |
|
| 17 | A review of the use of mexiletine in patients with myotonic dystrophy and non-dystrophic myotonia | |
| Simon D'Mello,Ling Shum |
| European Journal of Hospital Pharmacy.2016;23(6)359 |
| [DOI] |
|
